IBDEI1P1 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28791,0)
 ;;=O10.213^^115^1449^19
 ;;^UTILITY(U,$J,358.3,28791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28791,1,3,0)
 ;;=3^Pre-exist hyp chronic kidney disease comp preg, third tri
 ;;^UTILITY(U,$J,358.3,28791,1,4,0)
 ;;=4^O10.213
 ;;^UTILITY(U,$J,358.3,28791,2)
 ;;=^5016122
 ;;^UTILITY(U,$J,358.3,28792,0)
 ;;=O10.311^^115^1449^20
 ;;^UTILITY(U,$J,358.3,28792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28792,1,3,0)
 ;;=3^Pre-exist hyp heart and chr kidney dis comp preg, first tri
 ;;^UTILITY(U,$J,358.3,28792,1,4,0)
 ;;=4^O10.311
 ;;^UTILITY(U,$J,358.3,28792,2)
 ;;=^5016126
 ;;^UTILITY(U,$J,358.3,28793,0)
 ;;=O10.312^^115^1449^21
 ;;^UTILITY(U,$J,358.3,28793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28793,1,3,0)
 ;;=3^Pre-exist hyp heart and chr kidney dis comp preg, second tri
 ;;^UTILITY(U,$J,358.3,28793,1,4,0)
 ;;=4^O10.312
 ;;^UTILITY(U,$J,358.3,28793,2)
 ;;=^5016127
 ;;^UTILITY(U,$J,358.3,28794,0)
 ;;=O10.313^^115^1449^22
 ;;^UTILITY(U,$J,358.3,28794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28794,1,3,0)
 ;;=3^Pre-exist hyp heart and chr kidney dis comp preg, third tri
 ;;^UTILITY(U,$J,358.3,28794,1,4,0)
 ;;=4^O10.313
 ;;^UTILITY(U,$J,358.3,28794,2)
 ;;=^5016128
 ;;^UTILITY(U,$J,358.3,28795,0)
 ;;=O11.1^^115^1449^30
 ;;^UTILITY(U,$J,358.3,28795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28795,1,3,0)
 ;;=3^Pre-existing hypertension w pre-eclampsia, first trimester
 ;;^UTILITY(U,$J,358.3,28795,1,4,0)
 ;;=4^O11.1
 ;;^UTILITY(U,$J,358.3,28795,2)
 ;;=^5016142
 ;;^UTILITY(U,$J,358.3,28796,0)
 ;;=O11.2^^115^1449^31
 ;;^UTILITY(U,$J,358.3,28796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28796,1,3,0)
 ;;=3^Pre-existing hypertension w pre-eclampsia, second trimester
 ;;^UTILITY(U,$J,358.3,28796,1,4,0)
 ;;=4^O11.2
 ;;^UTILITY(U,$J,358.3,28796,2)
 ;;=^5016143
 ;;^UTILITY(U,$J,358.3,28797,0)
 ;;=O11.3^^115^1449^32
 ;;^UTILITY(U,$J,358.3,28797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28797,1,3,0)
 ;;=3^Pre-existing hypertension w pre-eclampsia, third trimester
 ;;^UTILITY(U,$J,358.3,28797,1,4,0)
 ;;=4^O11.3
 ;;^UTILITY(U,$J,358.3,28797,2)
 ;;=^5016144
 ;;^UTILITY(U,$J,358.3,28798,0)
 ;;=O10.13^^115^1449^33
 ;;^UTILITY(U,$J,358.3,28798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28798,1,3,0)
 ;;=3^Pre-existing hypertensive heart disease comp the puerperium
 ;;^UTILITY(U,$J,358.3,28798,1,4,0)
 ;;=4^O10.13
 ;;^UTILITY(U,$J,358.3,28798,2)
 ;;=^5016119
 ;;^UTILITY(U,$J,358.3,28799,0)
 ;;=O10.23^^115^1449^29
 ;;^UTILITY(U,$J,358.3,28799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28799,1,3,0)
 ;;=3^Pre-existing hyp chronic kidney disease comp the puerperium
 ;;^UTILITY(U,$J,358.3,28799,1,4,0)
 ;;=4^O10.23
 ;;^UTILITY(U,$J,358.3,28799,2)
 ;;=^5016125
 ;;^UTILITY(U,$J,358.3,28800,0)
 ;;=O10.33^^115^1449^23
 ;;^UTILITY(U,$J,358.3,28800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28800,1,3,0)
 ;;=3^Pre-exist hyp heart and chr kidney disease comp the puerp
 ;;^UTILITY(U,$J,358.3,28800,1,4,0)
 ;;=4^O10.33
 ;;^UTILITY(U,$J,358.3,28800,2)
 ;;=^5016131
 ;;^UTILITY(U,$J,358.3,28801,0)
 ;;=O13.1^^115^1449^4
 ;;^UTILITY(U,$J,358.3,28801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28801,1,3,0)
 ;;=3^Gestational htn w/o significant proteinuria, first trimester
 ;;^UTILITY(U,$J,358.3,28801,1,4,0)
 ;;=4^O13.1
 ;;^UTILITY(U,$J,358.3,28801,2)
 ;;=^5016158
 ;;^UTILITY(U,$J,358.3,28802,0)
 ;;=O13.2^^115^1449^5
 ;;^UTILITY(U,$J,358.3,28802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28802,1,3,0)
 ;;=3^Gestational htn w/o significant proteinuria, second trimester
 ;;^UTILITY(U,$J,358.3,28802,1,4,0)
 ;;=4^O13.2
